We are live on ! Find out more

20 hedge funds and large institutions have $150K invested in cbdMD in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

0.03% more ownership

Funds ownership: 0.6%0.63% (+0.03%)

0% more funds holding

Funds holding: 2020 (0)

22% less capital invested

Capital invested by funds: $193K → $150K (-$42.7K)

Holders
20
Holders Change
Holders Change %
0%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

YCBD Hedge Fund Activity: Q3 2023 in Review

20 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q3 2023, worth a combined $150K — down 22% from $193K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new YCBD positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 2 trimmed.

The largest buyer was AXS Investments, adding an estimated $34.5K. The largest seller was AdvisorShares Investments, exiting entirely with an estimated $23.3K sold.

  • 20 institutional investors held cbdMD (YCBD) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $150K of cbdMD stock for Q3 2023, down 22% quarter-over-quarter.
  • 3 funds opened new cbdMD positions in Q3 2023 and 2 closed out, a net change of +1 holder.
  • The largest cbdMD buyer in Q3 2023 was AXS Investments, an estimated $34.5K added.
  • The largest cbdMD seller in Q3 2023 was AdvisorShares Investments, an estimated $23.3K sold.

Based on aggregated 13F filings for Q3 2023.